SH3GL2 and glioblastoma: Thus, in the absence of other discriminatory markers, overexpression of DDP10, ETNPPL and SH3GL2 in DA + AA vs GBM might be considered in distinguishing these tumor subgroups, particularly for unclassifiable tumors or in case of small biopsy samples.